Neurology

BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction




BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction

Source link




Related posts

Two randomized migraine studies of galcanezumab: Effects on patient functioning and disability

Newsemia

Elevation of plasma lysosphingomyelin-509 and urinary bile acid metabolite in Niemann-Pick disease type C-affected individuals.

Newsemia

EBV-NMDA double positive encephalitis in an immunocompromised patient

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy